Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Change in Receivables: 2021-2022

Historic Change in Receivables for Solid Biosciences (SLDB) over the last 1 years, with Jun 2022 value amounting to -$14,000.

  • Solid Biosciences' Change in Receivables fell 333.33% to -$14,000 in Q2 2022 from the same period last year, while for Jun 2022 it was -$286,000, marking a year-over-year change of. This contributed to the annual value of -$110,000 for FY2022, which is 200.00% down from last year.
  • Per Solid Biosciences' latest filing, its Change in Receivables stood at -$14,000 for Q2 2022, which was up 85.42% from -$96,000 recorded in Q1 2022.
  • In the past 5 years, Solid Biosciences' Change in Receivables registered a high of $308,000 during Q3 2021, and its lowest value of -$484,000 during Q4 2021.
  • In the last 2 years, Solid Biosciences' Change in Receivables had a median value of -$4,000 in 2021 and averaged $0.
  • Data for Solid Biosciences' Change in Receivables shows a maximum YoY tumbled of 333.33% (in 2022) over the last 5 years.
  • Quarterly analysis of 2 years shows Solid Biosciences' Change in Receivables stood at -$484,000 in 2021, then crashed by 333.33% to -$14,000 in 2022.
  • Its Change in Receivables was -$14,000 in Q2 2022, compared to -$96,000 in Q1 2022 and -$484,000 in Q4 2021.